| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/22/1994 | EP0602761A1 Prevention and treatment of retroviral disease |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602237A1 N-acetylglucosaminyltransferase v coding sequences |
| 06/22/1994 | EP0602178A1 T cell receptor-based therapy for rheumatoid arthritis |
| 06/22/1994 | EP0602144A1 Dna sequences encoding gelonin polypeptide |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602046A1 Detection of feline immunodeficiency viruses |
| 06/22/1994 | EP0545951B1 Hrsv vaccine |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0409895B1 A pasteurella vaccine |
| 06/22/1994 | EP0403568B1 Synthetic peptide antigens for the detection of htlv-1 infection |
| 06/22/1994 | EP0302887B1 Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 06/22/1994 | EP0273040B1 Biological containment |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088217A Vaccines |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/21/1994 | USRE34644 Hepatitis-A viruses adapted to human fibroblast cells |
| 06/21/1994 | US5322936 Nucleic acids encoding trypanosoma cruzi heparin-binding protein |
| 06/21/1994 | US5322774 Procaryotic leader sequence in recombinant baculovirus expression system |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/21/1994 | CA1330378C Amine derivatives of folic acid analogs |
| 06/21/1994 | CA1330303C Composition and process to enhance the efficacy of a fish vaccine |
| 06/15/1994 | EP0601979A2 Exogenous antigens bound to hepatitis B virus envelope antigen |
| 06/15/1994 | EP0601859A2 Pharmaceutic composition comprising cancer-related antibodies |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601125A1 V$g(a)12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 06/15/1994 | EP0601108A1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/15/1994 | EP0600930A1 Diagnosis and treatment of autoimmune diseases |
| 06/15/1994 | EP0600884A1 PROTECTIVE FOUR AMINO ACID EPITOPE AGAINST $i(PLASMODIUM VIVAX) MALARIA |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/15/1994 | EP0374178B1 Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| 06/14/1994 | US5321124 Art (rev) protein of human T-cell leukemia virus |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320947 Immune reactivity to expressed activated oncogenes for diagnosis of malignancy |
| 06/14/1994 | US5320941 DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
| 06/10/1994 | CA2110543A1 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/09/1994 | WO1994012648A2 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/09/1994 | WO1994012641A1 Haemophilus outer membrane protein |
| 06/09/1994 | WO1994012640A1 RECOMBINANT NUCLEIC ACID, POLYPEPTIDE MATERIAL CODED THEREBY AND TRANSMISSION BLOCKING VACCINE BASED THEREON FOR CONTROLLING THE MALARIA PARASITE $i(PLASMODIUM FALCIPARUM ) |
| 06/09/1994 | WO1994012636A1 Method of controlling polypeptide production in bacteria |
| 06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012617A1 Hepatitis b virus vaccines |
| 06/09/1994 | WO1994012615A1 Mycoplasma diagnostic assay |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994012216A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | WO1994012213A1 Method of producing antibodies with conjugates of b-cell-antigen and denatured carrier |
| 06/09/1994 | WO1994012212A1 Human aids vaccine from revertant cattle virus |
| 06/09/1994 | WO1994012211A1 Virulence-specific bacterial dna sequence |
| 06/09/1994 | WO1994012202A1 ACTIVATION OF p53 PROTEIN |
| 06/09/1994 | WO1994012144A2 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | WO1994004565A3 Ipnv vaccine |
| 06/09/1994 | WO1994004180A3 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 06/09/1994 | WO1994002508A3 Polypeptide antigens of mycobacterium bovis |
| 06/09/1994 | CA2150477A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | CA2128705A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/08/1994 | EP0600723A2 Infectious bursal disease vaccine |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600326A2 Antigen peptide of streptolysin O and method of determination of streptolysin antibody |
| 06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0495896B1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means |
| 06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 06/07/1994 | US5318982 Inhibiting crosslinking of proteins |
| 06/07/1994 | US5318913 Reagent for the determination by hemagglutination of antibodies to bacterial toxins, method of preparation and application thereof |
| 06/07/1994 | CA1330145C Protein label and drug delivery system |
| 06/07/1994 | CA1330140C Crosslinked polymers and a process for their preparation |
| 06/07/1994 | CA1330139C Crosslinked polymers with carbonate ester groups, and a process for their preparation |
| 06/07/1994 | CA1330038C Methods and compositions for the use of hiv env polypeptides and antibodies thereto |
| 06/05/1994 | CA2089629A1 Antibodies against human spermatozoa having contraceptive activity obtained from the colostrum and/or milk of mammals immunized with human spermatozoa |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599077A2 Anti-metastatic vaccine |
| 06/01/1994 | EP0598818A1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598813A1 Immunostimulation |
| 06/01/1994 | EP0598759A1 Recombinant infectious bovine rhinotracheitis virus |
| 06/01/1994 | EP0514544B1 Immune complexes |
| 06/01/1994 | EP0439458B1 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1994 | EP0321481B1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316910 Bioassay for influenza A and B nucleoprotein |
| 05/31/1994 | US5316764 Immunization of dogs to form antibodies |
| 05/31/1994 | US5316763 Antitumor |